Selective Glycolysis Inhibitors (SGIs): Enabling Clinical Development of Novel Small Molecules for the Treatment of Advanced Prostate Cancer - Andy Hill CARE Fund

Browse All Past Grants

Selective Glycolysis Inhibitors (SGIs): Enabling Clinical Development of Novel Small Molecules for the Treatment of Advanced Prostate Cancer

Grant Information

Funding Opportunity	Breakthrough Seed Funding
Funding Cycle	Cycle 1
Award Date	May 2023
Institution / Organization	University of Washington
Principal Investigator(s)	Wesley Van Voorhis, MD, PhD

Questions about Grants?

Please contact CARE Fund with any feedback or questions you have regarding CARE Fund grant programs or the application process.

Contact CARE Fund